Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-09-07
1985-07-09
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548551, C07D20704, A61K 3140
Patent
active
045282994
ABSTRACT:
1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-propanone and its pharmaceutically acceptable acid addition salts, which are useful as centrally acting muscle relaxants in the treatment of spasticity in mammals including humans, process for the preparation thereof, and pharmaceutical composition containing said compound as an active ingredient.
REFERENCES:
patent: 3995047 (1976-11-01), Morita et al.
patent: 4181803 (1980-01-01), Morita et al.
patent: 4277474 (1981-07-01), Kobda et al.
Chemical Abstracts, 63, 13290g, (1965).
Ito Tsugutaka
Karasawa Tadahiko
Kon Tatsuya
Uno Hitoshi
Dainippon Pharmaceutical Co., Ltd.
Hollrah Glennon H.
Springer D. B.
LandOfFree
1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-909554